Please login to the form below

Not currently logged in
Email:
Password:

University College London

This page shows the latest University College London news and features for those working in and with pharma, biotech and healthcare.

GSK hands rare disease assets over to Orchard

GSK hands rare disease assets over to Orchard

gene and cell therapies, including University College London; Great Ormond Street Hospital; the University of Manchester; the University of California Los Angeles; and Boston Children’s Hospital.

Latest news

  • Behaviour change that inspires healthy decisions Behaviour change that inspires healthy decisions

    So, that's what we did. Back in March 2016, we began a collaboration with University College London's Centre for Behaviour Change, and specifically Professors Susan Michie, Robert West and

  • Dr Olivier Danos joins TxCell scientific advisory board Dr Olivier Danos joins TxCell scientific advisory board

    He has also served as director of the Gene Therapy Consortium at University College London, scientific director of Généthon, and senior research director for France's National Centre for Scientific Research

  • Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

    Robert West of University College London - one of the authors of the paper - said the results “ should reassure regulatory authorities, doctors and patients about the safety and effectiveness of medicines to

  • Printable pharma Printable pharma

    Scientists from the University of Nottingham in the UK have demonstrated the potential of the polypill by combining three different cardiovascular drugs - the ACE inhibitor captopril, diabetes drug glipizide and calcium ... As FDM printers are small and

  • Pharma trio join with top universities for new drug search Pharma trio join with top universities for new drug search

    Pharma trio join with top universities for new drug search. AZ, GSK and J&J join forces with Imperial, University College and Cambridge. ... Dubbed the Apollo Therapeutics, the new fund will see the three pharma companies work with Imperial College London

More from news
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • How can pharma better engage and empower patients who are socially disadvantaged? How can pharma better engage and empower patients who are socially disadvantaged?

    For those who are socially disadvantaged, Professor Michael Marmot’s work at University College London’s Institute of Health Equity shows how social injustice leads to health inequalities, and that education

  • Behaviour Change Behaviour Change

    The Centre for Behaviour Change is a unique initiative, harnessing the breadth and depth of academic expertise in behaviour change at University College London (UCL) to address key challenges facing society ... is senior teaching fellow and Australasian

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    Lawrence Honig of the Columbia University Medical Center and principal investigator of Expedition 3, presented the data at the meeting. ... In December, the UK DRI unveiled the University of Leuven’s Professor Bart De Strooper as its director, who will

  • Why health psychology should inform pharma strategy Why health psychology should inform pharma strategy

    Qualifications: BSc Psychology University of Sussex, 1st class honours; MSc Health Psychology University College London, Distinction.

  • Biosimilars: friend or foe for healthcare systems? Biosimilars: friend or foe for healthcare systems?

    One London-based budget-holder, Dr Anthony Grosso, who is principal pharmacist, and honorary associate professor in clinical pharmacy practice, at University College London Hospitals, sees a real lack of knowledge

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • UK Dementia Research Institute names director UK Dementia Research Institute names director

    Prof Bart De Strooper has been appointed as director of the UK Dementia Research Institute, and will lead the venture from University College London. ... Prof De Strooper is currently a professor of molecular medicine at the University of Leuven and

  • Artios Pharma appoints science strategy VP Artios Pharma appoints science strategy VP

    Francis Crick Institute in London. ... Dr Boulton is also an honorary professor at University College London, a fellow of the Academy of Medical Sciences and an elected member of the European Molecular Biology Organisation, from whom

  • Biogen Idec names head of gene therapy Biogen Idec names head of gene therapy

    Prior to Kadmon, Dr Danos acted as the director of the Gene Therapy Consortium of the University College of London and led a gene therapy research team at the Necker Hospital –

  • Emotive hires junior planner Emotive hires junior planner

    Burrows has a degree in neuroscience from King's College, London. She joins emotive directly from university, bringing “ excellent written communication and experience in digital impact evaluation”, said the agency.

  • New chair of the British Pharmacopoeia Commission New chair of the British Pharmacopoeia Commission

    drugs. He is head of the department of pharmaceutics at the University College of London (UCL) School of Pharmacy. “

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • emotive. grows medical writing capacity

    and medical writing roles at scientific institutions across the globe, including Singapore, Switzerland, London, Belgium, USA, and Italy. ... Dr Ann Gilliat, who has a PhD in the biology of ageing from the Institute of Healthy Ageing, University College

  • emotive. expands Medical Writing and Client Services teams

    Aki has a PhD in Molecular Microbiology from Bristol University and a BSc (Hons) in Medical Microbiology from the University of Edinburgh. ... Our new Senior Medical Writer, Ian Seymour, has a PhD in Biochemistry from University College London and a BSc

  • Patients: the essential ingredient in drug research

    Bodies such as the Research and Innovation Forum (at University College London) exist to make patient involvemen t the cornerstone of research, but these aren’ t available to everyone.

  • New insights into making behavioural change work

    One such model is the Behaviour Change Wheel (BCW), a comprehensive theory-based framework developed by Professor Susan Michie at University College London (UCL). ... For example, scientists from the Universityof Warwick and Coventry University undertook

  • PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

    in health – CHANGE– which was developed in collaboration with University College London’ s Centre for Behaviour Change.

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics